Sep / 2025

OncoDaily IO OncoDaily GI Hemostasis Today

Apr 21, 2024 11:55 am

Apr 21, 2024 9:24 am

Apr 21, 2024 8:54 am

Apr 21, 2024 8:05 am

Apr 20, 2024 8:30 pm

Apr 20, 2024 8:22 pm

Apr 20, 2024 8:17 pm

Apr 20, 2024 8:14 pm

Apr 20, 2024 8:10 pm

Apr 20, 2024 8:07 pm

…

555

…

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Some tips for patients undergoing radiation therapy for head and neck cancers by Aren Karapetyan

Christine Garcia: Celebrating the incredible women of Weill Cornell Hematology and Oncology!

Rana McKay wins the 2024 Christopher G. Wood Rising Star Award at IKCS Europe

New Paper Alert! Exploring the Potential of 18F-BMS-986229 PET for Noninvasive Assessment of PD-L1 Expression in Gastroesophageal Cancer

Tom Powles: Adjuvant pembrolizumab in clear cell renal cancer for the 1st time (KN564)

Allyson Ocean: It’s very important to tell your primary care doctor if you have a family history of pancreatic cancer

Paolo Tarantino: Tumor-infiltrating lymphocytes (TILs): not only prognostic in Triple-Negative Breast Cancer

Congratulations to the 2024 ASCO Annual Meeting Merit Award and Special Merit Award recipients – Conquer Cancer

Coral Olazagasti: A patient today told me I’m the best-dressed doctor he’s had

Lillian Siu: Apply for the CRIS Cancer-Princess Margaret drug development fellowship

Headlines

Some tips for patients undergoing radiation therapy for head and neck cancers by Aren Karapetyan

Christine Garcia: Celebrating the incredible women of Weill Cornell Hematology and Oncology!

Rana McKay wins the 2024 Christopher G. Wood Rising Star Award at IKCS Europe

New Paper Alert! Exploring the Potential of 18F-BMS-986229 PET for Noninvasive Assessment of PD-L1 Expression in Gastroesophageal Cancer

Tom Powles: Adjuvant pembrolizumab in clear cell renal cancer for the 1st time (KN564)

Allyson Ocean: It’s very important to tell your primary care doctor if you have a family history of pancreatic cancer

Paolo Tarantino: Tumor-infiltrating lymphocytes (TILs): not only prognostic in Triple-Negative Breast Cancer

Congratulations to the 2024 ASCO Annual Meeting Merit Award and Special Merit Award recipients – Conquer Cancer

Coral Olazagasti: A patient today told me I’m the best-dressed doctor he’s had

Lillian Siu: Apply for the CRIS Cancer-Princess Margaret drug development fellowship

Headlines

OncoDaily

Oncology

cancer

fight against cancer

Global fight against cancer

cancer care

Breast Cancer

ASCO

Lung cancer

Cancer research

MD Anderson Cancer Center

cancer awareness

NSCLC

ESMO

immunotherapy

cancer treatment

Research

ASCO24

Headlines

colorectal cancer

Childhood Cancer

prostate cancer

AACR

clinical trials

FDA

Dana-Farber Cancer Institute

UICC

American Cancer Society

European Cancer Organisation

NCI

National Cancer Institute

healthcare

SIOP

ASCO25

chemotherapy

Vivek Subbiah

AI

American Society of Clinical Oncology

Paolo Tarantino

IASLC

WHO

Robert Orlowski

multiple myeloma

Memorial Sloan Kettering Cancer Center

Zainab Shinkafi-Bagudu

radiation oncology

Myeloma Paper of the Day

cervical cancer

Myeloma

patient care

European School of Oncology

Sitemap